| Literature DB >> 26883277 |
Zongliang Jiang1,2, Patrick Harrington3, Ming Zhang2, Sadie L Marjani1,4, Joonghoon Park1, Lynn Kuo3, Csaba Pribenszky5, Xiuchun Cindy Tian1.
Abstract
High hydrostatic pressure (HHP) has been used to pre-condition embryos before essential, yet potentially detrimental procedures such as cryopreservation. However, the mechanisms for HHP are poorly understood. We treated bovine blastocysts with three different HHP (40, 60 and 80 MPa) in combination with three recovery periods (0, 1 h, 2 h post HHP). Re-expansion rates were significantly higher at 40 and 60 but lower at 80 MPa after vitrification-warming in the treated groups than controls. Microarray analysis revealed 399 differentially expressed transcripts, representing 254 unique genes, among different groups. Gene ontology analysis indicated that HHP at 40 and 60 MPa promoted embryo competence through down-regulation of genes in cell death and apoptosis, and up-regulation of genes in RNA processing, cellular growth and proliferation. In contrast, 80 MPa up-regulated genes in apoptosis, and down-regulated protein folding and cell cycle-related genes. Moreover, gene expression was also influenced by the length of the recovery time after HHP. The significantly over-represented categories were apoptosis and cell death in the 1 h group, and protein folding, response to unfolded protein and cell cycle in the 2 h group compared to 0 h. Taken together, HHP promotes competence of vitrified bovine blastocysts through modest transcriptional changes.Entities:
Mesh:
Year: 2016 PMID: 26883277 PMCID: PMC4756375 DOI: 10.1038/srep21215
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Experiment design of high hydrostatic pressure (HHP) treatment on cryopreserved bovine IVP blastocysts.
Figure 2Re-expansion rates (mean ± SD) of vitrified and thawed bovine IVP blastocysts upon different HHP treatments with a 2 h-recovery time.
(**P-value < 0.01, *P-value < 0.05; n = 3).
Figure 3(a) Hierarchical clustering of all 12,274 analyzed transcripts among different HHP treatments and recovery times. The three replicates per treatments are averaged, i.e., it is a clustering by treatment and not sample. Clear separations by HHP levels (0.1, 40, 60 and 80 MPa) were seen, demonstrating that pressure is a more significant factor than recovery time. (b) Heatmap of differentially expressed genes among different HHP treatments. The color spectrum, ranging from red to green, indicates normalized levels of gene expression from high to low.
Figure 4(a) The numbers of differentially expressed genes between HHP-treated embryos and controls. (b) Venn diagram shows the number of differentials specific to each comparison. (c) The numbers of differentially expressed genes between embryos allowed recovery time and controls. (d) Venn diagram shows the number of differentials specific to each comparison.
Representative gene ontology categories of differentially expressed genes affected by HHP treatment.
| 0.1 vs. 40 | Down-regulated | Cell death | 1.27E-04 | |
| Apoptosis | 2.55E-04 | |||
| Transition metal ion transport | 3.04E-02 | |||
| Up-regulated | RNA processing | 1.16E-06 | ||
| Translation | 2.82E-02 | |||
| Oxidative phosphorylation | 1.42E-02 | |||
| 0.1 vs. 60 | Down-regulated | Cell Death | 5.47E-05 | |
| Apoptosis | 4.35E-02 | |||
| Transition metal ion transport | 3.04E-02 | |||
| Up-regulated | RNA processing | 7.45E-06 | ||
| Transcription, DNA-dependent | 6.58E-03 | |||
| Translation | 4.34E-02 | |||
| 0.1 vs. 80 | Down-regulated | Protein folding | 1.53E-02 | |
| Response to unfolded protein | 1.86E-02 | |||
| Cell cycle | 2.53E-02 | |||
| Up-regulated | Chromatin assembly or disassembly | 1.38E-05 | ||
| Apoptosis and Cell Death | 3.38E-05 | |||
| Cellular Assembly and Organization | 1.17E-02 |
Figure 5Modified apoptotic pathways in HHP-treated embryos.
Genes in the green and red boxes were down- and up-regulated in both the 40- and 60-MPa treated groups (P-value < 0.05), respectively.
Representative gene ontology categories of differentially expressed genes affected by recovery time post-HHP.
| 0 vs. 1h | Down-regulated | Apoptosis | 1.27E-02 | |
| Proteolysis | 2.02E-02 | |||
| Phosphate metabolic process | 3.97E-02 | |||
| Up-regulated | Cellular growth and proliferation | 2.64E-03 | ||
| Cell Morphology | 1.74E-03 | |||
| Cellular Function and Maintenance | 1.39E-02 | |||
| 0 vs. 2 h | Down-regulated | Protein folding | 1.53E-02 | |
| Cell cycle | 2.53E-02 | |||
| Cell death | 3.92E-02 | |||
| Up-regulated | Cellular Growth and Proliferation | 6.24E-05 | ||
| DNA replication | 1.18E-02 | |||
| G1/S transition of mitotic cell cycle | 4.86E-02 |
Figure 6Comparisons of microarray and quantitative real-time RT-PCR (qRT-PCR) results of 8 selected genes from 40 (a) and 60 MPa (b) treated embryos. Fold change (mean ± SD) was expressed as the ratios of the levels in the 40 or 60 MPa treated embryos (n = 3) to those in the controls (0.1 MPa) (n = 3). In all cases, real time RT-PCR results substantiated the differential gene expression patterns from microarray.